Mazorelvimab, CAS 2419087-89-9

Product Description: Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Chao TY, et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl Trop Dis. 2017 Dec 20;11(12):e0006133. /[2]Chao TY, et al. In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models. Trop Med Infect Dis. 2020 Feb 21;5(1):31.

CAS Number: 2419087-89-9

Molecular Weight: N/A

Research Area: Infection

Solubility: 10 mM in DMSO

Target: RABV

• Artikelnummer: MEXHY-P99727-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99727-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK